CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 30 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $29,000 | -80.5% | 10,205 | -79.3% | 0.00% | – |
| Q1 2021 | $149,000 | -5.1% | 49,220 | -7.9% | 0.00% | – |
| Q4 2020 | $157,000 | -8.7% | 53,441 | 0.0% | 0.00% | – |
| Q3 2020 | $172,000 | -3.4% | 53,441 | 0.0% | 0.00% | – |
| Q2 2020 | $178,000 | -8.2% | 53,441 | 0.0% | 0.00% | – |
| Q1 2020 | $194,000 | -30.0% | 53,441 | -0.7% | 0.00% | – |
| Q4 2019 | $277,000 | -13.2% | 53,800 | 0.0% | 0.00% | – |
| Q3 2019 | $319,000 | -7.0% | 53,800 | 0.0% | 0.00% | – |
| Q2 2019 | $343,000 | +9.6% | 53,800 | 0.0% | 0.00% | – |
| Q1 2019 | $313,000 | -7.7% | 53,800 | 0.0% | 0.00% | – |
| Q4 2018 | $339,000 | +10.4% | 53,800 | 0.0% | 0.00% | – |
| Q3 2018 | $307,000 | -7.0% | 53,800 | 0.0% | 0.00% | – |
| Q2 2018 | $330,000 | -8.1% | 53,800 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $359,000 | -10.0% | 53,800 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $399,000 | +5.0% | 53,800 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $380,000 | 0.0% | 53,800 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $380,000 | +1.9% | 53,800 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $373,000 | +26.0% | 53,800 | 0.0% | 0.00% | – |
| Q4 2016 | $296,000 | +9.6% | 53,800 | 0.0% | 0.00% | – |
| Q3 2016 | $270,000 | +11.6% | 53,800 | 0.0% | 0.00% | – |
| Q2 2016 | $242,000 | 0.0% | 53,800 | 0.0% | 0.00% | – |
| Q1 2016 | $242,000 | -14.5% | 53,800 | 0.0% | 0.00% | – |
| Q4 2015 | $283,000 | -8.7% | 53,800 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $310,000 | -19.5% | 53,800 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $385,000 | +19.6% | 53,800 | 0.0% | 0.00% | – |
| Q1 2015 | $322,000 | 0.0% | 53,800 | 0.0% | 0.00% | – |
| Q4 2014 | $322,000 | +21.1% | 53,800 | 0.0% | 0.00% | – |
| Q3 2014 | $266,000 | +9.9% | 53,800 | 0.0% | 0.00% | – |
| Q2 2014 | $242,000 | +0.8% | 53,800 | 0.0% | 0.00% | – |
| Q1 2014 | $240,000 | -50.1% | 53,800 | -42.2% | 0.00% | -100.0% |
| Q4 2013 | $481,000 | +13.2% | 93,100 | -0.7% | 0.00% | 0.0% |
| Q3 2013 | $425,000 | -11.3% | 93,800 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $479,000 | – | 93,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 739,917 | $5,135,000 | 2.89% |
| JW Asset Management, LLC | 263,881 | $1,830,000 | 0.38% |
| BARD ASSOCIATES INC | 442,825 | $3,075,000 | 0.29% |
| Ariel Investments | 1,393,125 | $9,668,000 | 0.11% |
| TFS CAPITAL LLC | 11,499 | $80,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 293,700 | $2,038,000 | 0.02% |
| DELTA ASSET MANAGEMENT LLC/TN | 12,000 | $83,000 | 0.01% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 10,945 | $76,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 52,767 | $366,000 | 0.01% |
| Spark Investment Management LLC | 22,600 | $156,000 | 0.01% |